SWAV vs. INSP, CMD, NARI, RMD, WST, BAX, PODD, SOLV, TFX, and GMED
Should you be buying Shockwave Medical stock or one of its competitors? The main competitors of Shockwave Medical include Inspire Medical Systems (INSP), Cantel Medical (CMD), Inari Medical (NARI), ResMed (RMD), West Pharmaceutical Services (WST), Baxter International (BAX), Insulet (PODD), Solventum (SOLV), Teleflex (TFX), and Globus Medical (GMED). These companies are all part of the "medical" sector.
Inspire Medical Systems (NYSE:INSP) and Shockwave Medical (NASDAQ:SWAV) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.
Shockwave Medical has higher revenue and earnings than Inspire Medical Systems. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Shockwave Medical, indicating that it is currently the more affordable of the two stocks.
Inspire Medical Systems received 43 more outperform votes than Shockwave Medical when rated by MarketBeat users. Likewise, 61.03% of users gave Inspire Medical Systems an outperform vote while only 55.83% of users gave Shockwave Medical an outperform vote.
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 95.4% of Shockwave Medical shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 3.4% of Shockwave Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Inspire Medical Systems has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500. Comparatively, Shockwave Medical has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.
Shockwave Medical has a net margin of 20.75% compared to Shockwave Medical's net margin of -2.38%. Inspire Medical Systems' return on equity of 24.79% beat Shockwave Medical's return on equity.
Inspire Medical Systems currently has a consensus target price of $256.53, indicating a potential upside of 61.56%. Shockwave Medical has a consensus target price of $309.11, indicating a potential downside of 7.66%. Given Shockwave Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Inspire Medical Systems is more favorable than Shockwave Medical.
In the previous week, Inspire Medical Systems had 1 more articles in the media than Shockwave Medical. MarketBeat recorded 7 mentions for Inspire Medical Systems and 6 mentions for Shockwave Medical. Inspire Medical Systems' average media sentiment score of 1.47 beat Shockwave Medical's score of 1.29 indicating that Shockwave Medical is being referred to more favorably in the news media.
Summary
Shockwave Medical beats Inspire Medical Systems on 10 of the 18 factors compared between the two stocks.
Get Shockwave Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SWAV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Shockwave Medical Competitors List
Related Companies and Tools
